Loading...

APLT APPLIED THERAPEUTICS INC Operational Disruptions 8-K Filing

PPLD

PLT

APPLIED THERAPEUTICS INC

(APLT)

2024 8-K

Show Summary

Summary

Financial Statements

Financial Results

Leadership Changes

Board Resignation

FDA Warning Letter

FDA Response Letter

Financial Results

Earnings Reports

Annual Meeting of Stockholders

Financial Results Announcement

Appointment of Chief Commer...

FDA extends review period f...

Presentation and Trial Results

Earnings Reports

Private Placement and New D...

Positive Interim Results fr...

ARISE-HF Phase 3 Trial Results

NDA and MAA Submission

Appointment of Chief Operat...

Appointment of Chief Financ...

Earnings Report

Exchange Agreement with Ven...

Sales Agreement with Leerin...

Financial Results Announcement

Management Changes

Annual Meeting of Stockholders

Financial Results Announcement

Private Placement

Private Placement

Financial Results Announcement

Departure of Directors or P...

Exclusive License and Suppl...

External Links:

Applied Therapeutics announced the topline results of the ARISE-HF Phase 3 trial of AT-001 in patients with Diabetic Cardiomyopathy, showing a trend towards improvement but not statistically significant; plans to focus on partnering to bring AT-001 to patients.

AI Assistant

APPLIED THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.